On December 14, 2022, Medifron DBT Co., Ltd. closed the transaction. The company issued 3,427,600 shares in the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,242 KRW | -3.42% | +4.55% | -25.76% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
1,505 KRW | -0.33% | +1.69% | 92.3M | ||
1,242 KRW | -3.42% | +4.55% | 62.23M | ||
1st Jan change | Capi. | |
---|---|---|
-25.76% | 62.23M | |
-12.40% | 193B | |
+3.30% | 171B | |
+2.45% | 154B | |
+6.37% | 101B | |
+10.80% | 80B | |
+25.01% | 77.2B | |
-7.44% | 70.57B | |
-19.70% | 53.36B | |
-9.69% | 42.57B |
- Stock Market
- Equities
- A057680 Stock
- News T Scientific Co.,Ltd.
- Medifron DBT Co., Ltd. announced that it has received KRW 4.0000092 billion in funding from T Scientific Co.,Ltd